Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2024-02-09 5:34 pm Purchase | 13G | 908 DEVICES INC MASS | ARCH Venture Fund VII L.P. | 5,756,442 17.800% | 11,843 (+0.21%) | View |
| 2023-02-13 4:06 pm Purchase | 13G | 908 DEVICES INC MASS | ARCH Venture Fund VII L.P. | 5,744,599 18.100% | 12,313 (+0.21%) | View |
| 2022-02-11 4:55 pm Purchase | 13G | UNITY BIOTECHNOLOGY INC NE UBX | ARCH Venture Fund VII L.P. | 10,138,859 17.500% | 38,560 (+0.38%) | View |
| 2022-02-08 3:03 pm Purchase | 13G | 908 DEVICES INC MASS | ARCH Venture Fund VII L.P. | 5,732,286 18.500% | 6,440 (+0.11%) | View |
| 2021-02-04 2:03 pm Purchase | 13G | 908 DEVICES INC MASS | ARCH Venture Fund VII L.P. | 5,725,846 21.100% | 5,725,846 (New Position) | View |
| 2021-02-02 5:03 pm Purchase | 13G | UNITY BIOTECHNOLOGY INC NE UBX | ARCH Venture Fund VII L.P. | 10,100,299 19.100% | 38,559 (+0.38%) | View |
| 2021-02-02 5:02 pm Sale | 13G | Twist Bioscience Corp TWST | ARCH Venture Fund VII L.P. | 0 0.000% | -3,367,158 (Position Closed) | View |
| 2021-02-02 5:02 pm Sale | 13G | Syros Pharmaceuticals Inc. SYRS | ARCH Venture Fund VII L.P. | 0 0.000% | -3,341,770 (Position Closed) | View |
| 2020-02-14 12:26 pm Purchase | 13G | Twist Bioscience Corp TWST | ARCH Venture Fund VII L.P. | 3,367,158 10.200% | 5,590 (+0.17%) | View |
| 2020-02-13 4:51 pm Purchase | 13G | UNITY BIOTECHNOLOGY INC NE UBX | ARCH Venture Fund VII L.P. | 10,061,740 21.900% | 13,559 (+0.13%) | View |
| 2020-02-13 4:50 pm Sale | 13G | Syros Pharmaceuticals Inc. SYRS | ARCH Venture Fund VII L.P. | 3,341,770 7.900% | -1,295,367 (-27.93%) | View |